Revenue +30%, profit −27%: the FX one-time that explains the gap

The quarter opens with a paradox: revenue rocketed 30.2% to ₹601.7 crore, yet reported net profit fell 26.7% to ₹55.6 crore. But adjust for one-time items—an ₹18 crore FX hedging gain and ₹6.2 crore in RSU expenses—and adjusted PAT emerges at ₹62.9 crore, up 35.4% YoY. The real question: which number matters for a holder?

Revenue benefited from three tailwinds: organic volume growth, the Novigo acquisition, and rupee depreciation (a material currency boost that management explicitly acknowledged). On the profit side, reported PAT lagged because of the ₹18 crore FX hedging reclassification—a one-time item excluded from adjusted profit. Strip the one-time noise, and adjusted profit is +35.4% YoY, a respectable organic performance. But the adjusted figure comes with an asterisk: it excludes RSU expenses and non-recurring items, so its sustainability depends on whether those items recur.

Deal quality upgraded. Management named 5 large wins (telecom, fintech, insurance, financial services, ad-tech) and highlighted improving average deal size and contract duration. The AI-first narrative is gaining traction, and the HFS Horizon 2 GCC Accelerator recognition validates the differentiation strategy.

Organic growth execution downgraded. Despite optimistic messaging, constant-currency growth remains stuck at ~2%, less than half the 3–4% target. Management attributed delays to macro uncertainty and client decision-cycle lengthening but offered no catalyst timeline to bridge the gap.

ACV momentum flat. TTM bookings at $82.9M vs. $82.3M in Q1 FY-2027 (up $0.6M, essentially flat QoQ). Management relies on a 'lag effect'—H1 wins converting to H2 revenue—but the Q2 bookings don't yet show acceleration. Conversion timing and rate uncertain.

SG&A investment sharply increased. Deliberate spend-up: CRO hired, AI and domain experts added to sales, EXIQO AI studio brand launch. Management is betting on organizational muscle to drive pipeline conversion, but the ROI is execution-dependent.

Margin sustainability framed as FX-dependent. Management explicitly guided 18–19% adjusted EBITDA as the sustainable range, acknowledging that rupee depreciation is 'beyond our control' and a material contributor to the 20.1% reported margin. When FX winds reverse, margins will face 100–200 bps of headwind.

Post-result price action speaks skepticism. The stock fell 4.6% on day 1 (delivery 48.9%), faded to −7.96% by day 3, and widened to −9.44% by day 5. The initial pop didn't hold, suggesting the market found the adjusted-profit narrative and organic-growth weakness unconvincing. This is a contrarian signal: the market is repricing on execution risk, not valuation.

Deep drawdown from ATH; below all key averages. At ₹241.8, the stock is 44.5% below its all-time high of ₹435.9 and trading below its 20-day (₹252.41), 50-day (₹248.63), and 200-day (₹316.38) moving averages. The RSI of 41.2 is neutral, neither oversold nor overbought. The positioning suggests the market has already repriced for execution risk, and further downside may be limited if the company can prove CC growth acceleration in H2.

Institutional flows turning cautious. FII holdings are stable but near multi-quarter lows at 3.82% (up just 6 bps QoQ). DII holdings fell 207 bps QoQ to 6.53%, indicating domestic institutional trimming. This is not a vote of confidence; it suggests institutions are waiting for proof of execution before re-engaging.

Bulk/block trading quiet. No insider-linked selling near the highs, but volume trend is decreasing overall. The lack of significant bulk activity suggests limited conviction on either side of the trade—holders are neutral, and new buyers are cautious.